SESHP s 17 th Annual Meeting and Resident Forum

Transcription

1 SOUTHEAST SOCIETY OF HEALTH SYSTEM PHARMACISTS, CLEVELAND CLINIC FLORIDA & MEMORIAL HEALTH SYSTEM SESHP s 17 th Annual Meeting and Resident Forum Location: Jagelman Conference Center Cleveland Clinic Florida 2950 Cleveland Clinic Blvd. Weston, FL March 10 and 11, :00am-5:00pm Target Audience: Pharmacists, Technicians, Students, Nurses and Others in related Pharmaceutical Settings. We encourage participation by all qualified persons without regard to race, sex, creed, national origin or religion. Programming will provide an in-depth representation with fair, full disclosures and equitable balance. Continuing Education Maximum of 12.0 hours of C.E. credits. FSHP is accredited by the Accreditation Council for Pharmacy Education as a CE provider and will provide credit for General CE hours. FSHP is an approved Florida Board of Pharmacy CE Provider and will provide credit for Consultant Pharmacist Re-Certification hours. Cleveland Clinic Florida is an approved Florida Board of Nursing CE Provider and will provide credit for General Nursing CE hours. This program will host 8 clinical tracks for the following specialty areas: General Medicine I and II, Infectious Diseases, Health Care Administration, Critical Care, Cardiology, Oncology and Neurology During this program, speakers will: Review pathophysiology, clinical presentation, and diagnostic criteria for respective disease states. Review roles of the healthcare practitioner for managing patients with acute illnesses. Discuss drug therapy and treatment strategies of respective disease states including drug classes, dosing and pharmacology Explain patient assessment and monitoring for efficacy and side effects of drug therapy Mention importance of laboratory testing and drug interactions of drug therapy Identify new and emerging therapies for the treatment of respective disease states

2 Please register online at Pharmacists/ Residents: Early (By March 1 st ) Late or Onsite 2 Day Member: $100 $160 Non-Member: $160 $220 1 Day only Member: $60 $80 Non-Member: $80 $120 Technicians: 2 Day Member: $50 $70 Non-Member: $100 $120 1 Day only Member: $40 $60 Non-Member $60 $100 Students: 2 Day Member: $40 $50 Non-Member: $50 $60 1 Day only Member: $20 $30 Non-member: $30 $40 Nursing: Registrant (2 Day): $100 $160 Registrant (1 Day): $60 $80

3 SCHEDULE-AT-A-GLANCE Saturday March 10, 2018 Complimentary breakfast (7:00-8:00am) and lunch (12:00pm-1:00pm) available onsite for both Saturday and Sunday 7:00 8:00 am Registration TRACK 1: ADMINISTRTATION (3 hours) Jagelman Room 2/3 8:00 9:00 am 1 hour Value Based Purchasing HCAHPS, readmission rates, and health literacy Presenter: Jacqualine Igwe (PGY-1), Memorial Hospital Pembroke Review tools used to potentially improve patient experience (HCAHPS). Discuss best practices to potentially decrease readmission rates. Recognize how health literacy influences the different domains. Define hospital value-based purchasing domains. Identify methods in which hospitals are evaluated within each domain. Interpret the scoring approach used in value-based purchasing. 9:00 10:00 am 1 hour Collaborative Practice What does that mean? Presenter: Josh Lenchus, DO, RPh, FACP, SFHM Jackson Health System Contrast the historical pharmacist role from that of today. Assess potential benefits and disadvantages of provider status. Apply the information discussed to their future practice and how it may integrate a collaborative practice. Differentiate the role of technician and pharmacist. Explain the role of technician in the healthcare team. Determine the potential role of technician in a collaborative practice environment. 10:00-10:30 am BREAK / EXHIBITOR SHOWCASE 10:30 11:30 am 1 hour New Value Based Payment Models in Oncology: A Pharmacist s Primer Presenter: Frank Gentile (PGY2), Memorial Cancer Institute Define the Center for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM). Identify opportunities for the pharmacist to impact the OCM quality measures. Explain the difference between the new Quality Payment Programs and the Sustainable Growth Rate Formula in the oncology setting. Discuss pathway driven payer models and their effects on treatment choice. Define the Center for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM). Identify the pharmacy technician s role in the OCM quality measures. Discuss the pathway driven payer models and how they affect drug utilization.

4 11:30 am - 1:00 pm EXHIBITOR SHOWCASE 12:00-1:00 pm LUNCH TRACK 2: CARDIOVASCULAR (3 hours) Jagelman Room 2/3 1:00 2:00 pm 1 hour New Therapies for Chronic Heart Failure Presenter: Samantha Parsons (PGY1), North Broward Medical Center Describe the new medication's impact on the management of CHF and their place in therapy. Summarize pertinent research developments in CHF therapy and management. Describe the role of a pharmacist in therapy optimization and prevention of future readmissions. Discuss the pathophysiology of alcohol withdrawal syndrome. Differentiate between symptoms of alcohol withdrawal syndrome. Define the goals of treatment for detoxification of alcohol according to the American Society of Addiction Medicine. 2:00 3:00 pm 1 hour Perioperative Management of Antiplatelet/Anticoagulation Therapy Presenter: Heidi Perez (PGY1), North Broward Medical Center Explain how to determine the bleeding risk in patients undergoing a surgical procedure. Describe how to determine the thromboembolic risk in patients undergoing a surgical procedure. Determine appropriate timing of anticoagulation interruption. Determine when bridging is appropriate. Describe when restarting anticoagulation is appropriate. Identify medications that require special peri-operative management to avoid bleeding. Describe general recommendations to manage anticoagulation and antiplatelet medications. Comprehend the importance of appropriate perioperative management of anticoagulation and antiplatelet agents. 3:00-3:30 pm BREAK / EXHIBITOR SHOWCASE 3:30 4:30 pm 1 hour Updates in Anticoagulation Management in Special Populations Presenter: Suasy Acevedo (PGY1), Jackson Memorial Hospital Review considerations for anticoagulation therapy in special populations. Evaluate the literature for appropriate selection of anticoagulants in special populations. Discuss the use of DOACs in special populations. Define factors that classify patients into special populations. Discuss causes of prothrombotic tendencies in special populations. Identify anticoagulation therapy that can be used in special populations.

5 TRACK 4: Internal Medicine (3 hours) Jagelman Room 4/5 8:00-9:00 am 1 hour Improve Heart Failure Outcomes in Transition from Hospital to Home Presenter: Diana Christie (PGY1), Broward Health Medical Center Discuss the role of guideline-directed medical therapy in reducing hospitalizations in patient with chronic heart failure. Evaluate the role of newer agents for heart failure. Develop plans to optimize patient care with chronic heart failure using patient cases. Outline the pathophysiology of chronic heart failure Propose transitions of care services and program Discuss the role of pharmacists and pharmacy technicians in transitional care programs 9:00 10:00 am 1 hour Collaborative Practice What does that mean? Presenter: Josh Lenchus, DO, RPh, FACP, SFHM Jackson Health System Contrast the historical pharmacist role from that of today. Assess potential benefits and disadvantages of provider status. Apply the information discussed to their future practice and how it may integrate a collaborative practice. Differentiate the role of technician and pharmacist. Explain the role of technician in the healthcare team. Determine the potential role of technician in a collaborative practice environment 10:00-10:30 am BREAK / EXHIBITOR SHOWCASE 10:30 11:30 am 1 hour 2017 Updates in Hypertension Guidelines Presenter: Nayeli Montes (PGY1), Memorial Hospital West Identify major changes in the newly updated guidelines for management of hypertension and how they differ from established guidelines. Explore the potential impact of the guidelines on the general population. Discuss the importance of accurate blood pressure readings. Recommend initial blood pressure regimens for special populations. Identify patients that are at high risk for hypertension. Recognize patient s goal blood pressure. Identify life-style modifications for hypertensive patients. Explain to patient s the importance of medication adherence. 11:30 am - 1:00 pm EXHIBITOR SHOWCASE 12:00-1:00 pm LUNCH

6 TRACK 4: Critical Care (3 hours) Jagelman Room 4/5 1:00 2:00 pm 1 hour Review of Fluid and Electrolyte Abnormality Presenter: Stephanie Machin (PGY1), Jackson Memorial Hospital Recognize signs and symptoms of electrolyte and fluid abnormalities. Describe when and how to appropriately replace or replete electrolytes. Review management of fluid replacement. Describe distribution of total body fluid. Identify basic fluid and electrolyte abnormalities and review their common causes. Discuss the storage and handling of different fluids and electrolytes. 2:00 3:00 pm 1 hour Surviving Sepsis Update Presenter: Catherine Gandour (PGY1), Memorial Regional Hospital Review the differences between sepsis and septic shock. Discuss Lactate level s role in managing a septic patient. Review appropriate vasoactive agents in a septic patient. List appropriate timing of antibiotics. Discuss importance of fluid resuscitation. Review glucose control of a septic patient. 3:30 4:30 pm 1 hour 3:00-3:30 pm BREAK / EXHIBITOR SHOWCASE Management of Hepatic Encephalopathy Presenter: Pierina Cabrera (PGY2 Transplant), Jackson Memorial Hospital Review the pathogenesis and precipitating factors of hepatic encephalopathy (HE). Examine the current and novel therapies implicated in the management of HE. Propose a plan for the selection of therapies when managing HE based on published literature. List the clinical features of HE. Describe factors involved in the pathogenesis of HE. Identify drugs used in the management of HE.

7 SCHEDULE-AT-A-GLANCE Sunday, March 11, 2018 TRACK 5: CRITICAL CARE ll (3 hours) Jagelman Room 2/3 8:00 9:00 am 1 hour ACLS and Targeted Temperature Management Presenter: Jennifer Mijares (PGY1), Palmetto General Hospital Recognize criteria for initiating targeted temperature management following cardiac arrest. Evaluate and compare optimal temperature targets and durations. Identify available methods used to maintain temperature management. Discuss the role of targeted temperature management in improving patient outcomes. List the three phases to targeted temperature management. Recall complications associated with induction of hypothermia. 9:00 10:00 am 1 hour Management of Alcohol Withdrawal Presenter: Cheelove Cineas (PGY1), Memorial Regional Hospital Review the pharmacological management of alcohol withdrawal syndrome based on severity of symptoms. Differentiate between fixed-dose regimens versus symptom-triggered regimen used in alcohol withdrawal states. Discuss the role of adjunctive agents in patients with alcohol withdrawal syndrome. Technician Objective: Understand the pathophysiology of alcohol withdrawal syndrome. Differentiate between symptoms of alcohol withdrawal syndrome. Define the goals of treatment for detoxification of alcohol according to the American Society of Addiction Medicine. 10:00-10:30 am BREAK / EXHIBITOR SHOWCASE 10:30 11:30 am 1 hour Management of Ventricular Assist Devices and ECMO Presenter: Ravi Bacchus (PGY2- Critical Care), Jackson Memorial Hospital Compare and contrast the post-implantation anticoagulation and antiplatelet management for left ventricular assist devices (LVADs). Describe common adverse events associated with LVADs and extracorporeal membrane oxygenation (ECMO). Recommend pharmacologic treatments for the management of adverse events associated with LVADs and ECMO. List different types of mechanical circulatory support (MCS). Give examples of common adverse events associated with LVADs and ECMO. Identify antiplatelet and anticoagulant therapies recommended for LVADs.

8 11:30 am - 1:00 pm EXHIBITOR SHOWCASE 12:00-1:00 pm LUNCH TRACK 6: INFECTIOUS DISEASES (3 hours) Jagelman Room 2/3 1:00 2:00 pm 1 hour Review of Newer Antimicrobial Agents and Application to Practice Presenter: Jesse Fulmer (PGY2 Infectious Disease), Jackson Memorial Hospital List and summarize most recent antimicrobial agents. Distinguish unique properties and indications of these antimicrobials. Determine the appropriate application of these antimicrobials to clinical practice. List and summarize most recent antimicrobial agents. Determine appropriate handling, storage, and stability of these antimicrobials. Demonstrate appropriate preparation of these antimicrobials. 2:00 3:00 pm 1 hour Antimicrobial Stewardship Hospital Requirements and Best Practices Presenter: Julian Mattes (PGY1), Broward Health Medical Center Identify hospital requirements for ASP. Review current best practices of ASP. Discuss implications for inadequate ASP. Explain ways pharmacy technicians can stay up to date with current antibiotic practices. Identify the role of the pharmacy technician in ASP. Summarize the team efforts involved in managing a proper Antimicrobial Stewardship. 3:30 4:30 pm 1 hour Controversies with Vaccinations Presenter: Veronica Nunez (PGY1), Memorial Hospital Miramar Review contents of vaccine and adverse events associated with immunizations. Determine ways to overcome obstacles and pharmacist role in immunizations. Discuss current controversies with immunization and CDC recommendations. Review the definition of a vaccine and how they work. Identify the different types of immunizations available. Review storage, preparation, administration, and stability of vaccines.

9 TRACK 7: INTERNAL MEDICINE II (3 hours) Jagelman Room 4/5 8:00 9:00 am 1 hour Management of infective Endocarditis Presenter: Trang Leminh (PGY1), Cleveland Clinic Identify common pathogens and routes of acquisition associated with endocarditis. Discuss the differences between the types of valvular endocarditis. Review the guideline and evidence-based recommendations for treatment of infective endocarditis. Review what infective endocarditis is Discuss the importance of identifying and treating endocarditis Identify medications used to treat infective endocarditis 9:00 10:00 am 1 hour Update in Pulmonary Arterial Hypertension Presenter: Michelle Henninger (PGY1), Cleveland Clinic Highlight the treatment guidelines for pulmonary hypertension. Discuss emerging clinical evidence regarding the treatment strategies for pulmonary hypertension. Explore potential novel therapies and pathways in pulmonary hypertension. Identify the causes and risk factors for pulmonary hypertension. Explain the mechanism of action of selected agents in pulmonary hypertension. List the different medication classes and highlight commonly used agents including dosing and adverse events. 10:00-10:30 am BREAK / EXHIBITOR SHOWCASE 10:30 11:30 am 1 hour Management of Chronic Non-Cancer Pain Presenter: Xiao Lin (PGY1), Palmetto General Hospital Explain the pathophysiology of chronic pain. Select appropriate pharmacological agents for chronic pain management. Summarize CDC guideline recommendations for prescribing opioids. Differentiate between nociceptive and neuropathic pain. Identify maximum daily cumulative doses for common OTC pain medications. List nonpharmacological interventions for pain relief. 11:30 am - 1:00 pm EXHIBITOR SHOWCASE 12:00-1:00 pm LUNCH

10 TRACK 8: ONCOLOGY (3 hours) Jagelman Room 4/5 1:00 2:00 pm 1 hour New developments in the treatment of colorectal cancer Presenter: Katrina Piedra (PGY1), Jackson Memorial Hospital Review current colorectal guidelines. Assess literature updates and clinical benefits of new therapy treatment modalities in colorectal cancer. Discuss the role of targeted and immune therapy. Summarize key elements of chemotherapy used in treatment. Identify new agents used in treatment. Review storage and handling requirements of new agents. 2:00 3:00 pm 1 hour Review and Update of Biosimilars Presenter: Herman Powery II (PGY1), Memorial Regional Hospital Define the terms biosimilars, biologics, follow-on biologics, and interchangeability from a regulatory and legal perspective. Explain the process behind approving a biosimilar product and how it differs from traditional small molecule pharmaceutical approval. Describe the factors that influence biosimilar nomenclature. Apply the understanding of biosimilars to formulary management and decision making. Define the terms biosimilars, biologics, and follow-on biologics from a regulatory and legal perspective. Describe the factors that influence biosimilar nomenclature. Discuss the implications of housing a biosimilar in terms of safety, use, and storage. 3:30 4:30 pm 1 hour Oral Chemotherapy Pharmacist s Role in Adherence, Monitoring, and Safety Presenter: Valerie Llerena (PGY1), Joe DiMaggio Children s Hospital Review strategies to increase medication adherence. Summarize monitoring parameters for oral chemotherapy agents. Discuss potentially significant drug-drug and drug-food interactions with oral chemotherapy agents. Identify common barriers to oral chemotherapy adherence. Describe safe handling of oral chemotherapy. List tools available to mitigate financial barriers to oral chemotherapy access.